TOP POSTER Rare but Relevant: Non-HIV Related Kaposi Sarcoma Treated with Cryotherapy Brigitte Cochran, BS1, Alexis Arza, BS2, Vixey Silva, DO3, Kristen Stewart, MD4
TOP POSTER Effect of Photoaging Software on Sun-Protective Behaviors in Hawaiʻi Pickleball Players Ana Danko BS, Heather M. Zimmerman BS, Taylor Ho BS, Darcy Tokunaga BS, Amadeo Nierva BS (expected 2025), David J. Elpern MD, and David Horio MD
TOP POSTER Association Between Atopic Dermatitis and Vitiligo in the All of Us Database Minka Gill, BS, Mireya Cervantes, BS, Nickoulet Babaei, BS, Dahyeon Kim, BS, Seanna Yang, BS, Jashin J. Wu, MD
TOP POSTER Successful Use of Belimumab in Dapsone-Resistant Bullous Lupus Erythematosus Sheeva Shahinfar, BSA, Sarah Rivera De Peña, MD, Michael Wilkerson, MD
TOP POSTER Ten Year Follow Up Study on Dermatologic Access in Hawai’i Katelyn Stenger BS,1 Heather M. Zimmerman BSN,1 Ralina Karagenova MS,1 Ryan Keliʻi Shontell PhD,1 Douglas W. Johnson MD,1,2 and David J. Elpern MD3
A Systematic Review and Meta-Analysis of HLA-DR in Onychomycosis: HLA-DR8 Confers Susceptibility Andrew C. Cook BS, Nathan E. Cohen BS, Rishi S. Patel BS, Shannon C. South BS, Marcia C. Ballantyne MD
Combination Intramuscular HPV Vaccine, Intralesional Candida Antigen Immunotherapy, and Topical 5-FU for Multi-refractory Plantar Warts: A Case Report Sarah Garzione,BA. Natalie Nasser, MD FAAD
SPECTREM: Complete Clearance at Week 16 Across Special Sites in Guselkumab-Randomized Participants with Low Body Surface Area, Moderate Psoriasis B. Glick, MPH; J. Beecker, MD; J. Alonso Llamazares, MD, PhD; A. Moore, MD; T. Alkousakis, MD; K. Shah, PhD; O. Choi, MD, PhD; D. Chan, PhD; L. Park Wyllie, PharmD, PhD; J. Jeyarajah, PhD; K. Rowland, MS, ARNP; P. Lewis, PhD; G. Yadav, PhD; H. C. Hong, MD
SPECTREM: Significant Clearance at Week 16 Across the Full Range of Guselkumab-Randomized Participants with Low Body Surface Area, Moderate Psoriasis with Special Sites Involvement L. S. Gold, MD; B. Strober, MD, PhD; A. W. Armstrong, MD, MPH; T. Alkousakis, MD; K. A. Papp, MD, PhD; R. Langley, MD; O. Choi, MD, PhD; D. Chan, PhD; J. Jeyarajah, PhD; P. Lewis, PhD; V. Groysman, MD; M. G. Lebwohl, MD, PhD
Deucravacitinib in plaque psoriasis: laboratory parameters through 4 years of treatment in the phase 3 POETYK PSO-1, PSO-2, and LTE trials Neil J. Korman,MD, Thierry Passeron,MD, Yukari Okubo,MD, Jerry Bagel,MD, Richard B. Warren,MBChB, Lynda Spelman,MBBS, Kevin Winthrop,MD, Kim Hoyt,MS, Thomas Scharnitz,MD, Subhashis Banerjee,MD, Diamant Thaçi,MD, Mona Shahriari,MD, Linda Stein Gold,MD
TikTok Trends in Dermatology and Their Clinical Evidence Derya Turk (BS), Rajaa Shoukfeh (BS), Dilara Turk (MD), Taylor Adlam (MD), Geoffrey Potts (MD)
An evidence-based review on the treatment of psoriasis and comorbid conditions with glucagon-like peptide-1 receptor agonist Seanna Yang, B.S., Dahyeon Kim, B.S., Nickoulet Babaei, B.S., Minka Gill, B.S., Mireya Cervantes, B.S., Jashin J. Wu, M.D.